Annual SGA
$12.37 M
+$2.05 M+19.83%
December 31, 2023
Summary
- As of February 7, 2025, CAPR annual SGA is $12.37 million, with the most recent change of +$2.05 million (+19.83%) on December 31, 2023.
- During the last 3 years, CAPR annual SGA has risen by +$6.82 million (+123.08%).
- CAPR annual SGA is now at all-time high.
Performance
CAPR SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$3.30 M
+$402.10 K+13.86%
September 30, 2024
Summary
- As of February 7, 2025, CAPR quarterly SGA is $3.30 million, with the most recent change of +$402.10 thousand (+13.86%) on September 30, 2024.
- Over the past year, CAPR quarterly SGA has increased by +$402.10 thousand (+13.86%).
- CAPR quarterly SGA is now -15.72% below its all-time high of $3.92 million, reached on March 31, 2024.
Performance
CAPR Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$701.41 M
-$34.11 M-5.11%
September 30, 2024
Summary
- As of February 7, 2025, CAPR TTM SGA is -$701.41 million, with the most recent change of -$34.11 million (-5.11%) on September 30, 2024.
- Over the past year, CAPR TTM SGA has dropped by -$714.43 million (-5487.74%).
- CAPR TTM SGA is now -1178736.81% below its all-time high of -$59.50 thousand.
Performance
CAPR TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CAPR Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +19.8% | +13.9% | -5487.7% |
| 3 y3 years | +123.1% | +23.2% | -6897.0% |
| 5 y5 years | +150.7% | +23.2% | -6897.0% |
CAPR Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +62.4% | -15.7% | +56.1% | -74.9% | at low |
| 5 y | 5-year | at high | +243.8% | -15.7% | +276.8% | -143.7% | at low |
| alltime | all time | at high | -100.0% | -15.7% | -100.0% | <-9999.0% | at low |
Capricor Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $3.30 M(+13.9%) | $13.41 M(+3.0%) |
| Jun 2024 | - | $2.90 M(-26.0%) | $13.02 M(+1.2%) |
| Mar 2024 | - | $3.92 M(+19.1%) | $12.87 M(+4.1%) |
| Dec 2023 | $12.37 M(+19.8%) | $3.29 M(+13.2%) | $12.37 M(+5.2%) |
| Sep 2023 | - | $2.91 M(+5.7%) | $11.76 M(+3.0%) |
| Jun 2023 | - | $2.75 M(-19.5%) | $11.41 M(+3.6%) |
| Mar 2023 | - | $3.42 M(+27.4%) | $11.02 M(+6.8%) |
| Dec 2022 | $10.32 M(+35.6%) | $2.68 M(+4.6%) | $10.32 M(+5.8%) |
| Sep 2022 | - | $2.56 M(+8.8%) | $9.75 M(+8.5%) |
| Jun 2022 | - | $2.36 M(-13.2%) | $8.99 M(+6.7%) |
| Mar 2022 | - | $2.72 M(+28.3%) | $8.42 M(+10.6%) |
| Dec 2021 | $7.61 M(+37.3%) | $2.12 M(+17.5%) | $7.61 M(+8.9%) |
| Sep 2021 | - | $1.80 M(+0.6%) | $6.99 M(+7.7%) |
| Jun 2021 | - | $1.79 M(-6.1%) | $6.49 M(+2.8%) |
| Mar 2021 | - | $1.91 M(+27.6%) | $6.31 M(+13.8%) |
| Dec 2020 | $5.54 M(+54.1%) | $1.49 M(+14.7%) | $5.54 M(+12.5%) |
| Sep 2020 | - | $1.30 M(-19.2%) | $4.93 M(+8.6%) |
| Jun 2020 | - | $1.61 M(+41.5%) | $4.54 M(+20.7%) |
| Mar 2020 | - | $1.14 M(+29.8%) | $3.76 M(+4.5%) |
| Dec 2019 | $3.60 M(-27.1%) | $876.70 K(-3.9%) | $3.60 M(-6.0%) |
| Sep 2019 | - | $912.00 K(+9.6%) | $3.83 M(-8.3%) |
| Jun 2019 | - | $831.90 K(-14.8%) | $4.17 M(-7.7%) |
| Mar 2019 | - | $976.50 K(-11.6%) | $4.52 M(-8.4%) |
| Dec 2018 | $4.93 M(+3.5%) | $1.10 M(-12.3%) | $4.93 M(-2.6%) |
| Sep 2018 | - | $1.26 M(+6.9%) | $5.06 M(+3.5%) |
| Jun 2018 | - | $1.18 M(-15.2%) | $4.89 M(-1.4%) |
| Mar 2018 | - | $1.39 M(+12.3%) | $4.96 M(+4.2%) |
| Dec 2017 | $4.76 M(-3.5%) | $1.24 M(+13.7%) | $4.76 M(+1.8%) |
| Sep 2017 | - | $1.09 M(-12.7%) | $4.68 M(-3.5%) |
| Jun 2017 | - | $1.25 M(+4.9%) | $4.85 M(-3.7%) |
| Mar 2017 | - | $1.19 M(+3.0%) | $5.04 M(+2.1%) |
| Dec 2016 | $4.93 M(+12.8%) | $1.15 M(-8.4%) | $4.93 M(+1.6%) |
| Sep 2016 | - | $1.26 M(-12.2%) | $4.86 M(+6.3%) |
| Jun 2016 | - | $1.43 M(+32.2%) | $4.57 M(+12.5%) |
| Mar 2016 | - | $1.08 M(+0.7%) | $4.06 M(-7.1%) |
| Dec 2015 | $4.37 M(+44.9%) | $1.08 M(+10.8%) | $4.37 M(+9.9%) |
| Sep 2015 | - | $972.80 K(+5.0%) | $3.98 M(+4.0%) |
| Jun 2015 | - | $926.30 K(-33.6%) | $3.83 M(+7.3%) |
| Mar 2015 | - | $1.40 M(+103.8%) | $3.57 M(+18.0%) |
| Dec 2014 | $3.02 M(+36.6%) | $684.70 K(-16.5%) | $3.02 M(+0.2%) |
| Sep 2014 | - | $819.70 K(+23.1%) | $3.02 M(+9.3%) |
| Jun 2014 | - | $665.70 K(-21.9%) | $2.76 M(+6.7%) |
| Mar 2014 | - | $852.30 K(+25.7%) | $2.59 M(+17.1%) |
| Dec 2013 | $2.21 M(+61.9%) | $677.80 K(+20.2%) | $2.21 M(+41.9%) |
| Sep 2013 | - | $563.90 K(+14.4%) | $1.56 M(+12.0%) |
| Jun 2013 | - | $492.80 K(+3.9%) | $1.39 M(+54.9%) |
| Mar 2013 | - | $474.40 K(+1767.7%) | $897.00 K(-2.8%) |
| Dec 2012 | $1.36 M | $25.40 K(-93.6%) | $922.60 K(-34.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | $397.20 K(-20.6%) | $1.42 M(-30.6%) |
| Mar 2012 | - | $500.00 K(-3.6%) | $2.04 M(-3.6%) |
| Dec 2011 | $2.12 M(-4.3%) | $518.90 K(+3.9%) | $2.12 M(+1.9%) |
| Sep 2011 | - | $499.30 K(-4.6%) | $2.08 M(-7.3%) |
| Jun 2011 | - | $523.30 K(-9.0%) | $2.24 M(+3.6%) |
| Mar 2011 | - | $575.30 K(+19.9%) | $2.16 M(-2.2%) |
| Dec 2010 | $2.21 M(-35.2%) | $479.90 K(-27.7%) | $2.21 M(-8.6%) |
| Sep 2010 | - | $664.10 K(+49.1%) | $2.42 M(-7.8%) |
| Jun 2010 | - | $445.40 K(-28.5%) | $2.63 M(-26.6%) |
| Mar 2010 | - | $623.20 K(-9.4%) | $3.58 M(+4.7%) |
| Dec 2009 | $3.42 M(-12.9%) | $687.90 K(-20.8%) | $3.42 M(-7.0%) |
| Sep 2009 | - | $869.10 K(-37.8%) | $3.67 M(+1.4%) |
| Jun 2009 | - | $1.40 M(+202.2%) | $3.62 M(+13.7%) |
| Mar 2009 | - | $462.50 K(-51.1%) | $3.19 M(-18.8%) |
| Dec 2008 | $3.92 M(-12.4%) | $944.90 K(+15.4%) | $3.92 M(-6.0%) |
| Sep 2008 | - | $818.80 K(-14.7%) | $4.17 M(-29.5%) |
| Jun 2008 | - | $960.20 K(-19.9%) | $5.91 M(+7.2%) |
| Mar 2008 | - | $1.20 M(+0.4%) | $5.52 M(+23.3%) |
| Dec 2007 | $4.48 M(+2398.7%) | $1.19 M(-53.4%) | $4.48 M(+32.1%) |
| Sep 2007 | - | $2.56 M(+353.8%) | $3.39 M(+305.4%) |
| Jun 2007 | - | $564.80 K(+260.4%) | $835.70 K(+198.6%) |
| Mar 2007 | - | $156.70 K(+50.8%) | $279.90 K(+114.6%) |
| Dec 2006 | $179.20 K(+848.1%) | $103.90 K(+908.7%) | $130.40 K(+253.4%) |
| Sep 2006 | - | $10.30 K(+14.4%) | $36.90 K(+25.5%) |
| Jun 2006 | - | $9000.00(+25.0%) | $29.40 K(+26.2%) |
| Mar 2006 | - | $7200.00(-30.8%) | $23.30 K(+8.4%) |
| Dec 2005 | $18.90 K(-0.5%) | $10.40 K(+271.4%) | $21.50 K(+0.9%) |
| Sep 2005 | - | $2800.00(-3.4%) | $21.30 K(-3.2%) |
| Jun 2005 | - | $2900.00(-46.3%) | $22.00 K(0.0%) |
| Mar 2005 | - | $5400.00(-47.1%) | $22.00 K(+15.2%) |
| Dec 2004 | $19.00 K(+3.8%) | $10.20 K(+191.4%) | $19.10 K(+33.6%) |
| Sep 2004 | - | $3500.00(+20.7%) | $14.30 K(+9.2%) |
| Jun 2004 | - | $2900.00(+16.0%) | $13.10 K(-23.8%) |
| Mar 2004 | - | $2500.00(-53.7%) | $17.20 K(-6.5%) |
| Dec 2003 | $18.30 K(-37.5%) | $5400.00(+134.8%) | $18.40 K(+9.5%) |
| Sep 2003 | - | $2300.00(-67.1%) | $16.80 K(-27.3%) |
| Jun 2003 | - | $7000.00(+89.2%) | $23.10 K(-16.6%) |
| Mar 2003 | - | $3700.00(-2.6%) | $27.70 K(-5.5%) |
| Dec 2002 | $29.30 K(+32.0%) | $3800.00(-55.8%) | $29.30 K(-37.9%) |
| Sep 2002 | - | $8600.00(-25.9%) | $47.20 K(+22.3%) |
| Jun 2002 | - | $11.60 K(+118.9%) | $38.60 K(+38.4%) |
| Mar 2002 | - | $5300.00(-75.6%) | $27.90 K(+16.3%) |
| Dec 2001 | $22.20 K(+113.5%) | $21.70 K(>+9900.0%) | $24.00 K(+943.5%) |
| Sep 2001 | - | $0.00(-100.0%) | $2300.00(0.0%) |
| Jun 2001 | - | $900.00(-35.7%) | $2300.00(+64.3%) |
| Mar 2001 | - | $1400.00 | $1400.00 |
| Dec 2000 | $10.40 K(>+9900.0%) | - | - |
| Dec 1999 | $0.00 | - | - |
FAQ
- What is Capricor Therapeutics annual SGA?
- What is the all time high annual SGA for Capricor Therapeutics?
- What is Capricor Therapeutics annual SGA year-on-year change?
- What is Capricor Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Capricor Therapeutics?
- What is Capricor Therapeutics quarterly SGA year-on-year change?
- What is Capricor Therapeutics TTM SGA?
- What is the all time high TTM SGA for Capricor Therapeutics?
- What is Capricor Therapeutics TTM SGA year-on-year change?
What is Capricor Therapeutics annual SGA?
The current annual SGA of CAPR is $12.37 M
What is the all time high annual SGA for Capricor Therapeutics?
Capricor Therapeutics all-time high annual SGA is $12.37 M
What is Capricor Therapeutics annual SGA year-on-year change?
Over the past year, CAPR annual SGA has changed by +$2.05 M (+19.83%)
What is Capricor Therapeutics quarterly SGA?
The current quarterly SGA of CAPR is $3.30 M
What is the all time high quarterly SGA for Capricor Therapeutics?
Capricor Therapeutics all-time high quarterly SGA is $3.92 M
What is Capricor Therapeutics quarterly SGA year-on-year change?
Over the past year, CAPR quarterly SGA has changed by +$402.10 K (+13.86%)
What is Capricor Therapeutics TTM SGA?
The current TTM SGA of CAPR is -$701.41 M
What is the all time high TTM SGA for Capricor Therapeutics?
Capricor Therapeutics all-time high TTM SGA is -$59.50 K
What is Capricor Therapeutics TTM SGA year-on-year change?
Over the past year, CAPR TTM SGA has changed by -$714.43 M (-5487.74%)